Cargando…
OR19-5 The Impact Of High Dose Glucocorticoids On The Outcome Of Immune Checkpoint Inhibitor-related Thyroid Disorders And The Baseline TSH As A Predictive Biomarker
Thyroid disorders have emerged as one of the most common immune-related adverse events (irAEs) associated with immune checkpoint inhibitors (ICI) therapy, yet optimum management and biomarkers to predict vulnerable individuals remain unknown. High dose glucocorticoid (HDG) therapy is routinely recom...
Autores principales: | Min, Le, Ma, Chanjuan, Hodi, F. Stephen, Giobbie-Hurder, Anita, Barroso-Sousa, Romualdo, Tolaney, Sara, Kaiser, Ursula |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554839/ http://dx.doi.org/10.1210/js.2019-OR19-5 |
Ejemplares similares
-
SAT-426 Macro-Thyroid Stimulating Hormone (TSH) in Children
por: Hattori, Naoki, et al.
Publicado: (2020) -
TSH level as a risk factor of thyroid malignancy for nodules in euthyroid patients
por: Alaraifi, Abdulaziz K., et al.
Publicado: (2023) -
SAT467 Monitoring TSH Over Time May Not Be Necessary in Patients With Thyroid Nodules
por: Kaul, Sabrina, et al.
Publicado: (2023) -
SAT510 I-131 Therapy with Dosimetry for Advanced Thyroid Carcinoma: Recombinant TSH vs Thyroid Hormone Withdrawal
por: Awad, Dana, et al.
Publicado: (2023) -
MON-LB87 Recombinant Human TSH vs Thyroid Hormone Withdrawal Preparation for Radioiodine Ablation in Pediatric Differentiated Thyroid Cancer
por: Schumm, Max A, et al.
Publicado: (2020)